EVALUATION PROSPECTIVELY THE LEVEL OF REDUCTION IN COGNITIVE FUNCTIONS OF CANCER PATIENTS WHO ARE ON ACTIVE ONCOLOGY TREATMENTS AND USE CANNABIS. THE SECOND GOAL IS TO IDENTIFY HIGH-RISK GROUPS FOR COGNITIVE IMPAIRMENT DUE TO CANNABIS USE.: